India, Feb. 27 -- Oragenics Inc. (OGEN) announced the pricing of an underwritten public offering of 1.40 million shares of its common stock at a public offering price of $1.50 per share, for gross proceeds of $2.1 million, before deducting underwriting discounts and offering expenses payable by the company.
OGEN closed Tuesday's regular trading at $2.45 down $0.71 or 22.47%. In the after-hours trading the stock further dropped $0.64 or 26.12%.
In addition, the company has granted the underwriters a 45-day option to purchase up to an additional 210,000 shares of its common stock at the public offering price, less discounts, to cover over-allotments, if any.
The offering is expected to close on March 1, 2024, subject to satisfaction of cus...